LIVZON PHARMACEUTICAL GROUP INC.* 1513 (I) (II) 52122 2341 38 (www.hkexnews.hk)(www.livzon.com.cn) H 18322 24 H *
.............................................................. 1........................................................ 5 I................... 6 II................................... 19 III.................................................. 20 IV.......................................................... 21 V...................................................... 21................................................ 22.................................................. 23.................................................... 42 i
A 1.00 A A 1
38 H 1.00 H H 2
16 600380 571 3
2014 % * 4
LIVZON PHARMACEUTICAL GROUP INC.* 1513 38 99-101 1702 (I) (II) (i) (ii) (iii) * 5
(i) (ii) (iii) (iv) I. 6
(i) (ii) 7
7-ACAD7-ACA 90% (a)(b)(a) (c)(a)(b) 8
260 340 572 9
237.82 294.18 247.74 91.47%86.52% 307.74 53.80% 382.00421.00 473.00 10
7-ACA D7-ACA 7-ACAD7-ACA 85.72% 83.74% 81.19% 7-ACA D7-ACA 7-ACA 10.40% 12.74% 15.31% 96.12% 96.48% 96.50% 11
1. 7-ACAD7-ACA 2. 7-ACAD7-ACA 7-ACAD7-ACA 18.94% 7.67% 8.93% 23.43% 35.00% 35.00% 56.3623.70% 247.7484.21% 6,516.61 1,060.4019.43% 33.11% 12
(a) 21.55% (b) 50 10% (c) 21.91% 13
30%34%448,000 833,000 36.36%32.00% 16%19% (a) (b) 14
(a)(b) (c)(d) (e)(f)(g)(h) (a) (b) (c) (d) 10-12% 15
(a) (b) (a) 16
7-ACAD7-ACA (i) (ii) (iii) 17
(iv) (a)(b) (c) 116,301,300A 74,358,067H44.78% 14A 5% 14A 18
II. A 20161025 A 5 450.00 IV 19
2 III. 38 (www.hkexnews.hk)(www.livzon.com.cn) H 18322 24H 20
IV. V. Livzon Pharmaceutical Group Inc.* * 21
LIVZON PHARMACEUTICAL GROUP INC.* 1513 2341 * 22
44.78% A 5% A 23
(i) (ii) 13.84 24
I. (a)(b) (c) 25
1. 2. 3. 4. 5. 26
II. 7-ACAD7-ACA 7-ACAD7-ACA 90% (i) (ii)(i) (iii)(i)(ii) 27
http://www.ndrc.gov.cn7-acad7-aca 1 21 7-ACA D7-ACA 1 28
2 7-ACAD7-ACA 29
(i) (ii) (iii) III. (a)(b) (c) (d) (i)14a.55 (ii) 14A.56 30
IV. (i) (ii) 149.05 237.82 294.18 247.74 260 340 572 382 421 473 (i) (ii) (iii) (iv) 31
382.0 134.26 7-ACAD7-ACA 10.21%12.35% 19.41% i) (i) (ii) 1,139.19 33.11%1,516.34 10.40%12.74%15.31% 23.43%35.00%35.00% 32
0.1 (i) 31.8% 38%(ii) 30%34%(iii) (iv) 448,000 833,000 36.36% 33
http://www.sda.gov.cn/ 0.1 0.2500.1 0.2200 http://www.sda.gov.cn/ PFEUS 38.17% 600521CH 16.15% 300006CH 6.40% 000790CH 6.31% 690HK 33.5% 34
6.31% 38.17% 23.43%35.00% 23.43%35.00% 7-ACAD7-ACA 7-ACAD7-ACA 85.72%83.74%81.19% 7-ACAD7-ACA 18.94%7.67%8.93% 7-ACAD7-ACA (i) 21.55%(ii) (iii) 35
(a) (b) 342.02 634.92 36.25% 48.61%47.83%44.72% 36
23 35 10% 20 7.7% BCC Research LLCTechNavioBCC Research LLC TechNavioInfiniti Research Ltd., BCC Research LLC 37
40TechNavio501005,000 3.21% GDP 7-ACAD7-ACA ii) 1,811.561,594.23 7-ACAD7-ACA 293.97237.26 16.23%14.88% 149.05 294.18 40.49% 38
91.47%86.52% 247.74 84.21% 307.74 572.0053.8% 7-ACAD7-ACA iii) 39
1. 40.49% 2. 3. (i) (ii) (iii) 40
16 8 41
1. 2. XV(1) XV78 (2) 352(3) 116,301,300A (1) (2) 41.52% 27.32% 74,358,067H (1) (3) 51.07% 17.47% 275,990A 48,360A (4) 324,350A 0.12% 0.08% 176,540A 0.06% 0.04% 42
72,000,000 90% 48,277,046 742,415,520 (5) 790,692,566 49.92% 261,331,700 (1) (6) 49.00% (1) 46.78%90% (2) 108,640,4747,660,826 (3) (4) (5) (6) 43
352 3. XV23 336 116,301,300A (1) 41.52% 27.32% 74,358,067H (2) 51.07% 17.47% 116,301,300A (3) 41.52% 27.32% 74,358,067H (3) 51.07% 17.47% 100,763,218A 7,660,826A (4) 7,877,256A (5) 116,301,300A 41.52% 27.32% 74,358,067H (2) 51.07% 17.47% 74,358,067H (2) 51.07% 17.47% UBS Group AG 358,910H (6) 9,244,995H (6) 9,603,905H 6.60% 2.26% 63,200H (7) 0.04% 0.01% Value Partners Group Limited 7,337,090H (8) 5.04% 1.72% 44
(1) 108,640,4747,660,826 (2) (3) (4) (5) 200412 (6) 358,9109,244,9954,180 UBS AGUBS Asset Management (Hong Kong) LtdUBS Asset Management (Singapore) LtdUBS Fund Management (Luxembourg) S.A.UBS Fund Management (Switzerland) AGUBS Securities LLC30,183 2,067,122190,9806,925,3101,40030,000 (7) UBS AGUBS Securities LLC33,20030,000 33,200 (8) Value Partners Hong Kong LimitedValue Partners Limited 5% 45
4. 5. 6. (i)(ii)(iii) (iv) 46
8.10 7. 8. 1 6 47
9. 10. 99-101 1702 (a) (b) 22 (c) 2341 (d) 48